Concepedia

Bixia Weng

BW

Statistics

Publications

8

Citations

274

H-Index

8

Active since

2013

Affiliations

Wenzhou Medical University(Current)

First Affiliated Hospital of Wenzhou Medical University

Hangzhou First People's Hospital

Nanjing University of Science and Technology

Bixia Weng is an author at Wenzhou Medical University specializing in pharmacology, cancer pharmacology, and drug discovery.

Publications per year

2013–2018

8

Publications

8

A thiopyran derivative with low murine toxicity with therapeutic potential on lung cancer acting through a NF-κB mediated apoptosis-to-pyroptosis switch

Bixia Weng, Huimin Li, Haonan Wang et al. · APOPTOSIS · 2018 · 79 citations

, , +16

Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents

Jianzhang Wu, Yali Zhang, Yuepiao Cai et al. · Bioorganic & Medicinal Chemistry · 2013 · 63 citations

, , +13

Design, synthesis, anti-lung cancer activity, and chemosensitization of tumor-selective MCACs based on ROS-mediated JNK pathway activation and NF-κB pathway inhibition

Liping Chen, Bixia Weng, Jiabing Wang et al. · European Journal of Medicinal Chemistry · 2018 · 37 citations

, , +17

An Oxygen-Chelate Complex, Palladium Bis-acetylacetonate, Induces Apoptosis in H460 Cells via Endoplasmic Reticulum Stress Pathway Rather than Interacting with DNA

Yi Wang, Jie Hu, Yuepiao Cai et al. · Journal of Medicinal Chemistry · 2013 · 26 citations

, , +17

Synthesis, anti-tumor activity, and structure–activity relationships of curcumol derivatives

Ping Guo, Yuewu Wang, Bixia Weng et al. · Journal of Asian Natural Products Research · 2013 · 22 citations

, , +15

1–5 of 8